Literature DB >> 24357847

The Angelina effect: immediate reach, grasp, and impact of going public.

Dina L G Borzekowski1, Yue Guan2, Katherine C Smith2, Lori H Erby2, Debra L Roter2.   

Abstract

BACKGROUND: In May 2013, Angelina Jolie revealed in a New York Times opinion piece that she had undergone a preventive double mastectomy because she had a family history of cancer and carried a rare mutation of the BRCA1 gene. Media coverage has been extensive, but it is not obvious what messages the public took from this personal health story.
METHODS: We conducted a survey with a representative national online panel of 2,572 adults. Participants described their awareness and identified information sources for the Angelina Jolie news story. They also reported their understanding, reactions, perceptions, and subsequent activities related to the story. We asked questions pertaining to personal and societal breast cancer risk and hypothetical questions regarding preventive surgery if the respondent or a family member were in the same position as Ms Jolie. Demographic information was collected, as was family risk for breast and ovarian cancer, and a gauge of numeracy.
RESULTS: While three of four Americans were aware of Angelina Jolie's double mastectomy, fewer than 10% of respondents had the information necessary to accurately interpret Ms Jolie's risk of developing cancer relative to a woman unaffected by the BRCA gene mutation. Awareness of the Angelina Jolie story was not associated with improved understanding.
CONCLUSION: While celebrities can bring heightened awareness to health issues, there is a need for these messages to be accompanied by more purposeful communication efforts to assist the public in understanding and using the complex diagnostic and treatment information that these stories convey.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24357847     DOI: 10.1038/gim.2013.181

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  55 in total

1.  Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.

Authors:  Allison W Kurian; Kevin C Ward; Nadia Howlader; Dennis Deapen; Ann S Hamilton; Angela Mariotto; Daniel Miller; Lynne S Penberthy; Steven J Katz
Journal:  J Clin Oncol       Date:  2019-04-09       Impact factor: 44.544

2.  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Allison W Kurian; Monica Morrow; Ann S Hamilton; John J Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

3.  Breast cancer: why do women opt for contralateral prophylactic mastectomy?

Authors:  Aron Goldhirsch; Shari Gelber
Journal:  Nat Rev Clin Oncol       Date:  2014-07-08       Impact factor: 66.675

4.  High-Risk Palliative Care Patients' Knowledge and Attitudes about Hereditary Cancer Testing and DNA Banking.

Authors:  John M Quillin; Oluwabunmi Emidio; Brittany Ma; Lauryn Bailey; Thomas J Smith; In Guk Kang; Brandon J Yu; Oluwafemi Patrick Owodunni; Mohammed Abusamaan; Rab Razzak; Joann N Bodurtha
Journal:  J Genet Couns       Date:  2017-12-04       Impact factor: 2.537

5.  Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.

Authors:  Sommer Hayden; Sarah Mange; Debra Duquette; Nancie Petrucelli; Victoria M Raymond
Journal:  J Genet Couns       Date:  2017-01-16       Impact factor: 2.537

Review 6.  Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.

Authors:  Kerstin Rhiem; Rita Schmutzler
Journal:  Breast Care (Basel)       Date:  2014-12       Impact factor: 2.860

7.  "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.

Authors:  Carla L Fisher; Thomas Roccotagliata; Camella J Rising; David W Kissane; Emily A Glogowski; Carma L Bylund
Journal:  J Genet Couns       Date:  2016-07-30       Impact factor: 2.537

8.  Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.

Authors:  Se Ik Kim; Myong Cheol Lim; Dong Ock Lee; Sun-Young Kong; Sang-Soo Seo; Sokbom Kang; Eun Sook Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-05       Impact factor: 4.553

9.  Cancer Genetic Counseling and Testing in an Era of Rapid Change.

Authors:  Gillian W Hooker; Keelia Rhoads Clemens; John Quillin; Kristen J Vogel Postula; Pia Summerour; Rebecca Nagy; Adam H Buchanan
Journal:  J Genet Couns       Date:  2017-04-22       Impact factor: 2.537

10.  Issues Arising in Psychological Consultations to Help Parents Talk to Minor and Young Adult Children about their Cancer Genetic Test Result: a Guide to Providers.

Authors:  Andrea Farkas Patenaude; Katherine A Schneider
Journal:  J Genet Couns       Date:  2016-10-03       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.